Evidence map›Paper›PMID 36836739›Full record

ArticleLife (Basel, Switzerland)2023

Association of the Mannose-Binding Lectin 2 BB Genotype with COVID-19-Related Mortality.

Yasuyo Kashiwagi, Shinji Suzuki, Ryo Takahashi, Gaku Yamanaka, Yuji Hirai, Hisashi Kawashima

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. High productionHeliyon · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yasuyo KashiwagiDepartment of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo 160-0023, Japan.
Shinji SuzukiDepartment of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo 160-0023, Japan.
Ryo TakahashiDepartment of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo 160-0023, Japan.
Gaku YamanakaDepartment of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo 160-0023, Japan.
Yuji HiraiDepartment of Infectious Diseases, Tokyo Medical University Hachioji Medical Center, Tokyo 160-0023, Japan.
Hisashi KawashimaDepartment of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo 160-0023, Japan.
Tokyo Medical University · JPTokyo Medical University Hachioji Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mannose-binding lectin (MBL) is crucial in first-line immune defenses. There are still many unknown factors regarding the mechanisms causing variability in the clinical course of coronavirus disease 2019 (COVID-19). In Japan, there have been few reports to date regarding the association between MBL and COVID-19. It has been demonstrated that the

Indexed as

BB genotypecoronavirus disease 2019 (COVID-19)mannose-binding lectin (MBL)

Identifiers

PMID36836739
PMCPMC9961194
OpenAlexW4318588145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.